Pulse Biosciences Grants Equity Incentive Awards to New Employees
Pulse Biosciences, Inc (PLSE)
Last pulse biosciences, inc earnings: 11/7 03:42 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.pulsebiosciences.com
Company Research
Source: Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq:PLSE) (“Pulse Biosciences” or the “Company”), a novel bioelectric medicine company, announced today that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 102,500 shares of Pulse Biosciences common stock to recently hired non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on March 16, 2020.The 2017 Inducement Equity Incentive Plan is used exclusively to grant equity awards to individuals who were not previously an employee or non-employee director of Pulse Biosciences as an inducement material to such individual’s entering into employment with Pulse Biosciences in accordance with Nasdaq Marketplace Rule 5635(c)(4).The options have an exercise price of $5.23 per share, which is equal to the closing price of Pulse Biosciences common stock on March 16, 2020. The 102,500 shares underlying the option grants wi
Show less
Read more
Impact Snapshot
Event Time:
PLSE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PLSE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PLSE alerts
High impacting Pulse Biosciences, Inc news events
Weekly update
A roundup of the hottest topics
PLSE
News
- Pulse Biosciences, Inc. (NASDAQ: PLSE) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association [Yahoo! Finance]Yahoo! Finance
- Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid AssociationBusiness Wire
- Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial ResultsBusiness Wire
- Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of ElectrophysiologyBusiness Wire
PLSE
Sec Filings
- 10/31/24 - Form 8-K
- 10/30/24 - Form 10-Q
- 10/30/24 - Form 8-K
- PLSE's page on the SEC website